Hensel, M., Schneeweiss, A., Sinn, P., Egerer, G., Solomayer, E., Haas, R., . . . Ho, A. D. (2002). P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support. International journal of cancer, 100(3), . https://doi.org/10.1002/ijc.10478
Chicago-Zitierstil (17. Ausg.)Hensel, Manfred, Andreas Schneeweiss, Peter Sinn, Gerlinde Egerer, Erich-Franz Solomayer, Rainer Haas, Gunther Bastert, und Anthony Dick Ho. "P53 Is the Strongest Predictor of Survival in High-risk Primary Breast Cancer Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Support." International Journal of Cancer 100, no. 3 (2002). https://doi.org/10.1002/ijc.10478.
MLA-Zitierstil (9. Ausg.)Hensel, Manfred, et al. "P53 Is the Strongest Predictor of Survival in High-risk Primary Breast Cancer Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Support." International Journal of Cancer, vol. 100, no. 3, 2002, https://doi.org/10.1002/ijc.10478.